JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1677/joe.0.1630001
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (33)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hinson, J.
Right arrow Articles by Raven, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hinson, J.
Right arrow Articles by Raven, P.
Journal of Endocrinology, Vol 163, Issue 1, 1-5
Copyright © 1999 by Society for Endocrinology

Articles

DHEA deficiency syndrome: a new term for old age?

JP Hinson and PW Raven


Dehydroepiandrosterone (DHEA) is a steroid secreted by the adrenal cortex, with a characteristic, age-related, pattern of secretion. The decline of DHEA concentrations with age has led to the suggestion that old age represents a DHEA deficiency syndrome and that the effects of ageing can be counteracted by DHEA 'replacement therapy'. DHEA is increasingly being used in the USA, outside medical supervision, for its supposed anti-ageing effects. This commentary weighs the evidence for the existence of a DHEA deficiency syndrome and considers the value of DHEA 'replacement therapy'.


This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
H. R. N. Pour, D. E Grobbee, M. Muller, M. Emmelot-Vonk, and Y. T van der Schouw
Serum sex hormone and plasma homocysteine levels in middle-aged and elderly men
Eur. J. Endocrinol., December 1, 2006; 155(6): 887 - 893.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
C Suarez, J Vela, I Garcia-Tornadu, and D Becu-Villalobos
Dehydroepiandrosterone (DHEA) modulates GHRH, somatostatin and angiotensin II action at the pituitary level
J. Endocrinol., April 1, 2005; 185(1): 165 - 172.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. J. Kahn and B. Halloran
Dehydroepiandrosterone Supplementation and Bone Turnover in Middle-Aged to Elderly Men
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1544 - 1549.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
A. Khalil, J.-P. Fortin, J.-G. LeHoux, and T. Fülöp
Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation
J. Lipid Res., October 1, 2000; 41(10): 1552 - 1561.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
K. Rose, A. Allan, S. Gauldie, G. Stapleton, L. Dobbie, K. Dott, C. Martin, L. Wang, E. Hedlund, J. R. Seckl, et al.
Neurosteroid Hydroxylase CYP7B. VIVID REPORTER ACTIVITY IN DENTATE GYRUS OF GENE-TARGETED MICE AND ABOLITION OF A WIDESPREAD PATHWAY OF STEROID AND OXYSTEROL HYDROXYLATION
J. Biol. Chem., June 22, 2001; 276(26): 23937 - 23944.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society for Endocrinology.